i asked the chief executive, lars fruergaard jargensen, about regulatory pressures and future growth.o, how do you think about pricing? again, you must have gotten some difficult questions from governments, but also, this goes back to innovation. lars: most products are priced according to the value they bring. and i feel really good about the value of our medicines, what they bring to the individual patient, but also the value to the health care system. and we have, today, health care systems around the world who were typically designed for acute care. but finding that 80% of the cost in the health care system is linked to chronic care. and we have portfolio products that are really addressing some of the chronic diseases of our day and age, diabetes, obesity, and the comorbidities that follow that. we know that there are protections that say, by 2035, the world obesity organization predicts that the cost burden to society will be $4 trillion of people living with obesity. and that cost is going to, to a large degree, turn out to be taken up by health care systems, who are already st